03/06/2024 5:18 PM | Atara Biotherapeutics (Issuer) Murugan Amar (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 5:18 PM | Atara Biotherapeutics (Issuer) Nguyen AnhCo (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 5:19 PM | Atara Biotherapeutics (Issuer) Touchon Pascal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 5:16 PM | Atara Biotherapeutics (Issuer) Henrich Jill (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 5:17 PM | Atara Biotherapeutics (Issuer) Hyllengren Eric J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 7:17 PM | Atara Biotherapeutics (Subject) Murugan Amar (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024 7:18 PM | Atara Biotherapeutics (Subject) Hyllengren Eric J (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
|
03/04/2024 7:19 PM | Atara Biotherapeutics (Subject) Henrich Jill (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024 7:21 PM | Atara Biotherapeutics (Subject) Touchon Pascal (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024 7:13 PM | Atara Biotherapeutics (Subject) Nguyen Tran (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/23/2024 3:30 PM | Atara Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/06/2024 3:45 PM | Atara Biotherapeutics (Subject) GOLDMAN SACHS GROUP INC (Filed by) GOLDMAN SACHS GROUP INC (Filed by)
| Form SC 13G/A | |
01/22/2024 12:58 PM | Atara Biotherapeutics (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/09/2024 3:40 PM | Atara Biotherapeutics (Issuer) Henrich Jill (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 3:40 PM | Atara Biotherapeutics (Issuer) Hyllengren Eric J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 3:40 PM | Atara Biotherapeutics (Issuer) Murugan Amar (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 3:40 PM | Atara Biotherapeutics (Issuer) Nguyen AnhCo (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 3:41 PM | Atara Biotherapeutics (Issuer) Touchon Pascal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 3:28 PM | Atara Biotherapeutics (Filer)
| Form 424B5 | |
01/09/2024 3:22 PM | Atara Biotherapeutics (Subject) BAUPOST GROUP LLC/MA (Filed by)
| Form SC 13G/A | |
01/08/2024 7:11 AM | Atara Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/20/2023 3:30 PM | Atara Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/07/2023 1:45 PM | Atara Biotherapeutics (Subject) JPMORGAN CHASE & CO (Filed by) JPMORGAN CHASE & CO (Filed by)
| Form SC 13G/A | |
11/20/2023 4:31 PM | Atara Biotherapeutics (Issuer) Nguyen AnhCo (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/20/2023 4:31 PM | Atara Biotherapeutics (Issuer) Touchon Pascal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/20/2023 4:29 PM | Atara Biotherapeutics (Issuer) Henrich Jill (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/20/2023 4:29 PM | Atara Biotherapeutics (Issuer) Hyllengren Eric J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/20/2023 4:30 PM | Atara Biotherapeutics (Issuer) Joshi Manher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/20/2023 4:30 PM | Atara Biotherapeutics (Issuer) Murugan Amar (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/17/2023 3:31 PM | Atara Biotherapeutics (Filer)
| Form 424B3 | |
11/14/2023 5:27 PM | Atara Biotherapeutics (Issuer) DOBMEIER ERIC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/14/2023 5:29 PM | Atara Biotherapeutics (Issuer) HEIDEN WILLIAM K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/13/2023 11:15 PM | Atara Biotherapeutics (Filer)
| Form EFFECT | |
11/08/2023 8:16 PM | Atara Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/01/2023 4:25 PM | Atara Biotherapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
11/01/2023 7:35 AM | Atara Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/01/2023 7:40 AM | Atara Biotherapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/18/2023 5:25 PM | Atara Biotherapeutics (Issuer) Henrich Jill (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/18/2023 5:25 PM | Atara Biotherapeutics (Issuer) Joshi Manher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/18/2023 5:25 PM | Atara Biotherapeutics (Issuer) Nguyen AnhCo (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/18/2023 5:25 PM | Atara Biotherapeutics (Issuer) Touchon Pascal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
The ONE AI sSock to own now. (It’s not Nvidia.) (Ad) Don’t panic — you haven’t missed the boat on AI.
In fact, it has barely launched.
Sure, the early stages of this boom were big …
But I believe the real wealth in AI has yet to be made … Click here to see the presentation now. |
08/18/2023 5:25 PM | Atara Biotherapeutics (Issuer) Murugan Amar (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/18/2023 5:25 PM | Atara Biotherapeutics (Issuer) Hyllengren Eric J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/29/2023 3:15 PM | Atara Biotherapeutics (Issuer) Touchon Pascal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/02/2023 7:06 PM | Atara Biotherapeutics (Issuer) SEIDENBERG BETH C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/02/2023 6:08 PM | Atara Biotherapeutics (Issuer) HEIDEN WILLIAM K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/02/2023 6:09 PM | Atara Biotherapeutics (Issuer) DOBMEIER ERIC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/02/2023 6:09 PM | Atara Biotherapeutics (Issuer) MALLIK AMEET (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/02/2023 6:09 PM | Atara Biotherapeutics (Issuer) Fust Matthew K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/02/2023 6:09 PM | Atara Biotherapeutics (Issuer) Gallagher Carol Giltner (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/02/2023 6:09 PM | Atara Biotherapeutics (Issuer) Roncarolo Maria Grazia (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/18/2023 7:17 PM | Atara Biotherapeutics (Issuer) Hyllengren Eric J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/18/2023 7:17 PM | Atara Biotherapeutics (Issuer) Touchon Pascal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/18/2023 7:17 PM | Atara Biotherapeutics (Issuer) Banard Charlene A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/18/2023 7:17 PM | Atara Biotherapeutics (Issuer) Murugan Amar (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/07/2023 3:45 PM | Atara Biotherapeutics (Issuer) Hyllengren Eric J (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/07/2023 3:35 PM | Atara Biotherapeutics (Filer)
| Form DEFA14A | |
04/07/2023 3:30 PM | Atara Biotherapeutics (Filer)
| Form DEF 14A | |
03/31/2023 3:31 PM | Atara Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |